Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
New figures show the number of babies admitted to hospital with respiratory viruses has trebled in just a year, according to Manx Care.
Flu and RSV are packing a post-holiday one-two punch, sending people into Erie's emergency departments and medical offices ...
7. New RSV prevention options for infants and pregnant mothers A new RSV prevention option for infants was introduced in 2023: the monoclonal antibody treatment Beyfortus (nirsevimab). This shot is ...
The novel treatment consists of a single shot which is made of special proteins called antibodies that bind to the site at ...
“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...
Doctors say it is important to know what you have to not only treat the illness, but to also know how long it could be ...
Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results